Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Cephalon, U.S. states reach $125 million settlement over generic drugs

Cephalon has reached a $125 million settlement with 48 states in connection with its alleged efforts to delay generic versions of its blockbuster sleep disorder drug Provigil from entering the market, New York Attorney General Eric Schneiderman said.

Read More »

Victoza Does Not Help Severe Heart Failure

A widely prescribed diabetes drug failed to reduce deaths or rehospitalizations in a study of patients with advanced heart failure.

Read More »

Sarepta Stock Surges After Government Website Indicates Firm is Recruiting for Phase III Study

After the May 25 announcement that the U.S. Food and Drug Administration was delaying its decision on approval of Sarepta Therapeutics’ eteplirsen for Duchene Muscular Dystrophy (DMD), investors have been waiting often impatiently for news. Although neither the FDA nor Sarepta have said anything, company stock jumped when, the website that provides information about clinical trials, showed that the company’s Phase III ESSENCE trial for DMD had started recruiting patients.

Read More »

Myriad Genetics Acquires Startup Assurex Health

Myriad Genetics has signed a definitive deal to acquire Assurex Health for $225 million upfront with the potential for $185 million in performance-based milestones.

Read More »

Banner Health says hackers may have gained access to patient data

Banner Health, a non-profit organization that runs a chain of hospitals, said hackers may have gained unauthorized access to patient, physician and beneficiary data.

Read More »

U.S. health researchers test Zika vaccine

U.S. government researchers said they have begun their first clinical trial of a Zika vaccine while the Obama administration told lawmakers funds to fight the virus would run out in the coming weeks.

Read More »

Pentagon says 33 U.S. military personnel infected with Zika

Thirty-three members of the U.S. military, including a pregnant woman, are believed to have contracted the mosquito-borne Zika virus overseas, the Pentagon said.

Read More »

Memory may someday benefit from electric therapy

It may someday be possible to send weak currents of electricity through the scalp during sleep to help improve memory for motor tasks, researchers say.

Read More »

GM mosquitoes could join Florida’s Zika fight

Genetically modified (GM) mosquitoes could be let loose in Florida’s battle against the Zika virus if regulators approve them, according to British firm Oxitec.

Read More »

CVS drops Sanofi’s diabetes drugs for biosimilars

U.S. pharmacy benefit manager CVS will drop Sanofi’s main insulin drug Lantus from the list of medicines it reimburses on behalf of health insurers.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

August 2019 Focus: AI, AR/VR, Top 200 Medicines, Lions Health Takeaways, and more!


Ad Right Bottom